Clinical Trials

Myeloproliferative Disorder, Chronic, with Eosinophilia, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT05543330 2026-05-14

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

Phase 1/2 Recruiting

96 enrolled

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT07443020 2026-04-07

RIOT 4B

10 enrolled

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07192900 2026-01-15

(RIOT 4A)

10 enrolled

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT05620329 2025-10-16

UNC Pleural Fluid Registry

Recruiting

9,999 enrolled

BreastThoracic

Breast Neoplasms, Empyema, Infections, Lung Neoplasms, Neoplasms, Pleural Effusion, Malignant

NCT07147270 2025-08-29

Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound

30 enrolled

Pleural Effusion, Malignant

NCT07120867 2025-08-13

Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial

95 enrolled

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

NCT06016179 2025-05-22

RIOT2

12 enrolled

Pleural Effusion, Malignant

NCT06959719 2025-05-07

ARMSTRONG

41 enrolled

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Pleural Effusion, Malignant

NCT06946498 2025-04-27

FLAT

100 enrolled

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Pleural Effusion, Pleural Effusion, Malignant

NCT06740019 2025-04-04

A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

30 enrolled

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

NCT06726564 2024-12-10

A Study of MT027 in Patients with Pleural Malignant Tumors

18 enrolled

Mesothelioma, Malignant, Neoplasm Metastasis, Pleural Effusion, Malignant

NCT06682936 2024-11-12

Feasibility of Ambulatory Talc. Pleurodesis

15 enrolled

Phase EARLY_PHASE1 Recruiting

Neoplasms, Pleural Effusion, Malignant

NCT04684459 2024-10-30

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

18 enrolled